Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MYGN · against 482 other Healthcare companies of similar size
Ranked #410 of 483 · scores higher than 15% of peers · safety percentile 17
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)40 peers with a safety percentile of 10–19, including MYGN · Click a bar to see the companies
Mainly because of its beta and debt / equity, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | MYGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 450 reported | 0.69× | 0.17× | 17% | 33% | |
| BetaLower is better · 460 reported | 1.68 | 0.40 | 6% | 33% | |
| Current ratioHigher is better · 478 reported | 2.21× | 2.88× | 40% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.2B USD | 100 | 40 | |
| 2 | 1.1B USD | 100 | ||
| 3 | 1.0B USD | 99 | 35 | |
| 4 | 421M USD | 99 | 52 | |
| 5 | 397M USD | 99 | 37 | |
| 406 | 588M USD | 18 | 24 | |
| 407 | 771M EUR (≈$848M) | 17 | 53 | |
| 408 | 3.5B CNY (≈$496M) | 17 | 38 | |
| 409 | 725M USD | 17 | 19 | |
| 410 | 578M USD | 17 | 22 | |
| 411 | 1.18T KRW (≈$847M) | 17 | 63 | |
| 412 | 595M USD | 17 | 29 | |
| 413 | 578M USD | 16 | 73 | |
| 414 | 7.1B CNY (≈$988M) | 16 | 46 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score